AHL Partners’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-11,895
Closed -$596K 1340
2017
Q3
$596K Buy
+11,895
New +$608K 0.01% 1006
2017
Q2
Sell
-11,608
Closed -$645K 1207
2017
Q1
$645K Buy
11,608
+6,709
+137% +$370K 0.01% 915
2016
Q4
$255K Sell
4,899
-6,096
-55% -$294K 0.01% 991
2016
Q3
$531K Buy
10,995
+1,301
+13% +$65.8K 0.02% 818
2016
Q2
$537K Buy
9,694
+1,807
+23% +$99.5K 0.03% 592
2016
Q1
$421K Sell
7,887
-46,633
-86% -$2.3M 0.03% 603
2015
Q4
$2.81M Buy
54,520
+44,576
+448% +$2.21M 0.22% 163
2015
Q3
$449K Sell
9,944
-90,731
-90% -$4.29M 0.07% 420
2015
Q2
$4.66M Sell
100,675
-10,437
-9% -$457K 0.19% 216
2015
Q1
$4.76M Buy
111,112
+48,052
+76% +$1.83M 0.19% 211
2014
Q4
$2.19M Buy
+63,060
New +$2.09M 0.11% 417

Other funds holding PBH

AHL Partners's PBH Position: Q4 2017 in Review

AHL Partners sold out of Prestige Consumer Healthcare (PBH) in Q4 2017, closing a stake of 11,895 shares — an estimated $596K sold.

AHL Partners first reported a position in PBH in Q4 2014 and held it in 11 quarters. The position peaked at $4.76M in Q1 2015. 251 funds tracked by Wall St. Rank hold PBH as of Q4 2017.

  • AHL Partners reported no remaining Prestige Consumer Healthcare position as of Q4 2017 after selling out during the quarter.
  • AHL Partners sold 11,895 Prestige Consumer Healthcare shares in Q4 2017, an estimated $596K.
  • AHL Partners first reported a position in Prestige Consumer Healthcare in Q4 2014 and held it in 11 quarters.
  • AHL Partners's Prestige Consumer Healthcare position peaked at $4.76M in Q1 2015.
  • 251 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.